Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Standard oral formulations achieve only 0.7% bioavailability, limiting blood level increases compared to IV delivery
topical formulations key differences GHK-Cu is available in multiple delivery formats, each with different bioavailability profiles, appropriate use cases, and levels of clinical oversight required
89 These clinical trials provide sound scientific evidence that supports the therapeutic efficacy of TLK286 in managing different types of malignancies
Part of this research was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA
Glenn Center for the Biology of Aging, a Professor of Genetics at Harvard Medical School, Associate Member of the Broad Institute for Systems Biology, and co-founder of Sirtris Pharmaceuticals, Waltham, MA
